CTCX Historical PE Ratio image   This CTCX PE ratio history page last updated 5/17/2024
CTCX Historical PE Ratio Chart
Q1 2024
Q4 2023
Q3 2023
Q2 2023
CTCX PE History Chart
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Quotes delayed 20 minutes

Email EnvelopeFree CTCX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Carmell Therapeutics (CTCX) is categorized under the Miscellaneous sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CVAC PE Ratio History
CVT PE Ratio History
CWK PE Ratio History
DAVE PE Ratio History
DFLI PE Ratio History
DMAC PE Ratio History
DOOR PE Ratio History
DSEY PE Ratio History
EFTR PE Ratio History
EG PE Ratio History
How should the CTCX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Carmell Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CTCX Historical PE Ratio page.

What is the average historical PE for CTCX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CTCX historical PE ratio using the annualized quarterly earnings method works out to 17.7.

What is the average historical PE for CTCX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CTCX historical PE ratio using the TTM earnings method works out to 3.9.

On this page we presented the CTCX Historical PE Ratio information for Carmell Therapeutics' stock. The average CTCX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 17.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CTCX historical PE based on this TTM earnings result method is 3.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CTCX historical PE result, against the recent PE: when this page was posted on 5/16/2024, the most recent closing price for CTCX had been 2.28, and the most recent quarterly earnings result, annualized, was 5.4. Meanwhile, the most recent TTM earnings summed to 0.59. From these numbers, we calculate the recent CTCX PE on 5/16/2024 based on annualized quarterly EPS was 0.4. Based on CTCX's history, that recent PE is low relative to the historical average, with the recent PE 97.7% lower than the historical average PE across our data set for Carmell Therapeutics. Looking at the recent CTCX PE on 5/16/2024 based on TTM EPS, we calculate the ratio at 3.9.

For self directed investors doing their due diligence on CTCX or any other given stock, valuation analysis for CTCX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Carmell Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CTCX. Thanks for visiting, and the next time you need to research CTCX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ETFs Holding BAH, AMR Insider Buying, FIRE Insider Buying.


CTCX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.